Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Autophagy in tumor immune escape and immunotherapy
Huan Wang, Peng Sun, Xijing Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 14
Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment
Mengnan Zhou, Jianqi Wu, Yang Shao, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112881-112881
Closed Access | Times Cited: 10
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 23
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer
Hee Jo Yang, Jae Heon Kim
Investigative and Clinical Urology (2023) Vol. 64, Iss. 1, pp. 3-3
Open Access | Times Cited: 19
Gut microbiome: a novel preventive and therapeutic target for prostatic disease
Hongliang Cao, Difei Zhang, Pengyu Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Diet and the microbiome as mediators of prostate cancer risk, progression, and therapy response
Angélica Cruz-Lebrón, Tasnim Syakirah Faiez, Megan M. Hess, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer
Shaun Trecarten, Michael A. Liss, Jill Hamilton‐Reeves, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Role of Microbiota‐Derived Metabolites in Prostate Cancer Inflammation and Progression
Pradeep Kumar Rathinavelu, Anil Kumar, Virendra Kumar
Cell Biochemistry and Function (2025) Vol. 43, Iss. 2
Open Access
CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches
Louis Boafo Kwantwi, James Danquah Boafo, Bevelyn Emefa Egleh, et al.
Clinical & Translational Oncology (2025)
Open Access
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
Mingyao Huang, Quansong Ji, Huiyan Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies
Mingyao Huang, Yikai Zhang, Zhaoji Chen, et al.
Pharmacological Research (2025) Vol. 215, pp. 107726-107726
Open Access
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting
Qi Liu, Mingyuan Song, Bin Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189341-189341
Closed Access
Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value
Chou‐Yi Hsu, Saade Abdalkareem Jasim, Khetam H. Rasool, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 3, pp. 152344-152344
Closed Access
New insights into gut microbiota–prostate cancer crosstalk
Jalal Laaraj, Gabriel Lachance, Alain Bergeron, et al.
Trends in Molecular Medicine (2025)
Closed Access
Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer
Dechao Feng, Jie Wang, Ruicheng Wu, et al.
European Urology (2024) Vol. 85, Iss. 5, pp. 498-499
Closed Access | Times Cited: 3
Fecal microbiome transfer an investigative tool and treatment strategy in cancer
Margaret S. Bohm, A. Ramesh, Joseph F. Pierre, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 327, Iss. 5, pp. G711-G726
Closed Access | Times Cited: 3
Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies
Rahamat Unissa Syed, Maali D. Alshammari, Humera Banu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7421-7437
Closed Access | Times Cited: 2
Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors
Bingquan Wu, Chao Quan, Yunbo He, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 747-759
Closed Access | Times Cited: 2
Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study
Shao-Yu Yue, Weiyi Li, Shun Xu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Porous starch microspheres loaded with luteolin exhibit hypoglycemic activities and alter gut microbial communities in type 2 diabetes mellitus mice
Xiaodong Ge, Tingting Liu, Yaolin Wang, et al.
Food & Function (2024)
Closed Access | Times Cited: 2
Dietary inulin ameliorates obesity-induced severe acute pancreatitis via gut-pancreas axis
Xin Li, Pan Zheng, Yaoyu Zou, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Microbiota-Derived Short-Chain Fatty Acids Boost Antitumoral Natural Killer Cell Activity
Marina Pérez, Berta Buey, Pilar Sánchez- Corral, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3885-3885
Open Access | Times Cited: 2
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives
Dengxiong Li, Ruicheng Wu, Qingxin Yu, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 6, pp. 596-615
Open Access | Times Cited: 2
The role of intratumoral microorganisms in the progression and immunotherapeutic efficacy of head and neck cancer
Xuzhe Fang, Weihong Tong, Sheng Wu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 349-360
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top